Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 5—May 2011
Research

Travel-related Dengue Virus Infection, the Netherlands, 2006–2007

Gijs G.G. BaatenComments to Author , Gerard J.B. Sonder, Hans L. Zaaijer, Tom van Gool, Joan A.P.C.M. Kint, and Anneke van den Hoek
Author affiliations: Author affiliations: Public Health Service, Amsterdam, the Netherlands (G.G.G. Baaten, G.J.B. Sonder, J.A.P.C.M. Kint, A. van den Hoek); Academic Medical Centre, Amsterdam (G.G.G. Baaten, G.J.B. Sonder, H.L. Zaaijer, T. van Gool, A. van den Hoek); National Coordination Centre for Traveller’s Health Advice, Amsterdam (G.G.G. Baaten, G.J.B. Sonder)

Main Article

Table 4

Signs and symptoms among travelers with seroconversion in antibody level for dengue virus in 1,207 persons who traveled from the Netherlands to dengue-endemic countries, October 1, 2006–September 30, 2007*

Sign or symptom Total no. Recent DENV, no. (PR, %) PRR (95% CI) p value
Fever, temperature >38°C 113 5 (4.4) 5.6 (1.8–17.0) 0.002
No fever 1,094 9 (0.8) 1
Headache 398 5 (1.3) 1.1 (0.38–3.4) 0.83
No headache 809 9 (1.1) 1
Retro-orbital pain 100 4 (4.0) 4.6 (1.4–14.8) 0.011
No retro-orbital pain 1,107 10 (0.9) 1
Myalgia 166 5 (3.0) 3.6 (1.2–10.8) 0.024
No myalgia 1,041 9 (0.9) 1
Arthralgia 72 3 (4.2) 4.4 (1.2–16.3) 0.025
No arthralgia 1,135 11 (1.0) 1
Rash 105 5 (4.8) 6.1 (2.0–18.5) 0.001
No rash 1,102 9 (0.8) 1
Diarrhea 581 10 (1.7) 2.7 (0.85–8.7) 0.092
No diarrhea 626 4 (0.6) 1
Dengue-like illness† 89 5 (5.6) 7.3 (2.4–22.4) <0.0001
No dengue-like illness 1,118 9 (0.8) 1

*DENV, dengue virus infection; PR, prevalence rate; PRR, prevalence rate ratio; CI, confidence intervals. Boldface indicates significance (p<0.5).
†Fever (temperature >38°C) with >1 of the following: myalgia, arthralgia, headache, retro-orbital pain, or skin rash.

Main Article

Page created: August 08, 2011
Page updated: August 08, 2011
Page reviewed: August 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external